Evidence map›Paper›PMID 39731352›Full record

Observational studyHeadache2025

The Chronic Headache Self-Efficacy Scale: Development and assessment of measurement properties.

Lori M Ginoza, Erica Sigman, Lori A Michener, Rachel K Straub, Soma Sahai-Srivastava, Federico Pozzi

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Headache, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lori M GinozaDivision of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California, USA.
Erica SigmanDivision of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California, USA.
Lori A MichenerDivision of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California, USA.
Rachel K StraubDivision of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California, USA.
Soma Sahai-SrivastavaDepartment of Neurology, University of Southern California, Los Angeles, California, USA.
Federico PozziDepartment of Physical Therapy, University of Florida, Gainesville, Florida, USA.ORCID 0000-0002-6384-9605

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
Southern California Clinical and Translational Science InstituteUL1TR000130 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BUCHANAN, THOMAS A · 2012 to 2015
$36.0M
National Center for Advancing Translational Science (NCATS) of the U.S. National Institutes of Health UL1TR000130National Center for Advancing Translational Science (NCATS) of the U.S. National Institutes of Health UL1TR001855NCATS NIH HHS UL1 TR000130NCATS NIH HHS UL1 TR001855
6 · The paper itself

Abstract

objectiveTo develop and assess the psychometrics of the Chronic Headache Self-Efficacy Scale (CHASE).

backgroundExisting scales assess self-efficacy in coping strategies and management of symptoms and triggers but do not measure other important self-efficacy domains, such as performing daily activities and socializing in patients with chronic daily headache (CDH).

methodsThe study had two phases: (i) Development of the 14-item CHASE, with items derived from patients with CDH and a multidisciplinary healthcare team; (ii) longitudinal observational study for psychometric evaluation. Participants with CDH (N = 79) completed the CHASE, Headache Management Self-Efficacy Scale (HMSE), six-item Headache Impact Test-6 (HIT-6), and 12-item Short Form Health Survey (SF-12) at baseline, 24-72 h after baseline, and 12 weeks after baseline. The Global Rating of Change (GROC) assessed perceived change in symptoms. We assessed internal consistency, day-to-day reliability, convergent and known group discriminant validity, dimensionality, and responsiveness via minimal clinical important difference (MCID).

resultsFor day-to-day reliability, the CHASE intraclass correlation coefficient was 0.68 (95% confidence interval 0.49-0.81), with standard error of measurement and minimal detectable change of 10.3% and 24%, respectively. The CHASE had two independent factors (total R

conclusionThe CHASE is a reliable and valid questionnaire for assessing self-efficacy in performing daily activities, socializing, managing headache symptoms and triggers, and guiding treatment plans for patients with CDH.

Indexed as

Headache DisordersPsychometricsSelf EfficacyAdultAgedFemaleHumansLongitudinal StudiesMaleMiddle AgedReproducibility of ResultsSurveys and QuestionnairesYoung Adultchronic daily headachemigrainepatient‐reported outcomepsychometric analysisreliabilityvalidity

Identifiers

PMID39731352
PMCPMC11884225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.